MDRNA, Inc. Issued Patent For The Use Of Nucleic Acids To Treat Cancer

Links shared publicly online about this topic.

  • 1,425
    total visits

MDRNA, Inc. Issued Patent For The Use Of Nucleic Acids To Treat Cancer

medicalnewstoday.com

Mdrna, inc. (nasdaq: mrna), a leading rnai-based drug discovery and development company, today announced that the state intellectual property office of the people's republic of china (prc) has iss

View full resource at medicalnewstoday.com

Tags: Cancer, Drug

  • Share

Most Recently Shared on January 27, 2010 at 4:08 pm By:

mnt_cancer MNT Cancer News

MDRNA, Inc. Issued Patent For The Use Of Nucleic Acids To Treat Cancer http://mnt.to/3wPj #cancer

2 years ago...

MDRNA granted Chinese patent for use of nucleic acids in cancer treatment

news-medical.net — “MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced that the State Intellectual Property Office of the People's Republic of China (PRC) has issued a Notification of Granting Patent Rights for PRC 200480018784 which includes the use of nucleic acids, e.g., an siRNA, for the treatment of cancer. The patent describes modulation of claudins, which are proteins implicated in tumor progression and metastasis.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on January 27, 2010 at 10:52 am By:

NewsMedical News-Medical.Net Health News

MDRNA granted Chinese patent for use of nucleic acids in cancer treatment: MDRNA, Inc., a leading RNAi-based drug ... http://bit.ly/9aSEQD

2 years ago...

Advertisement